ASTH Astrana Health, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Astrana Health, Inc. (ASTH) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 12, 2026, a 10-Q quarterly report filed on November 10, 2025, an 8-K current report filed on March 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Astrana Health, Inc. (ASTH) (SEC CIK 1083446), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: Physician-centric, technology-powered, risk-bearing healthcare platform focused on value-based care delivery and coordination for 1.6 million patients
- • New emphasis on expanded Care Enablement segment integrating clinical, operational, financial, and administrative data via proprietary technology suite
Management Discussion & Analysis
- • Revenue $3.18B in 2025, up $1.15B vs $2.03B in 2024, ~56% YoY growth driven by acquisitions and organic growth
- • Adjusted EBITDA $205.4M, up from $170.4M in 2024, margin decreased to 6% from 8% YoY
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Updated investor presentation filed March 4, 2026 for use at conferences and investor meetings
- • Full substance in Exhibit 99.1 — key metrics, strategy, and guidance context found there
Item 8.01: Other Events
- • Buyback authorization doubled from $50M to $100M, signaling board confidence in stock's intrinsic value
- • 633,844 shares repurchased in Q4 2025; $35.9M remained under old program as of Dec 31, 2025
Item 2.02: Results of Operations and Financial Condition
- • Q1 2025 earnings results disclosed via press release (Exhibit 99.1) — refer to exhibit for all financial figures
- • Filing structured as Reg FD-compliant disclosure; press release not subject to Section 18 liability
Item 7.01: Regulation FD Disclosure
- • Astrana Health furnishing Reg FD disclosure — signals management is sharing material non-public info with the broader market to ensure fair access
- • Filing explicitly "not filed" under Exchange Act Section 18 — limits shareholder litigation liability for the disclosed information
Annual Reports Archive10-K
AI-powered analysis of Astrana Health, Inc. (ASTH) 10-K annual reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Astrana Health, Inc. (ASTH) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $1.1B | $1.4B | $2.0B | $3.2B |
| Operating Income | $104.3M | $84.6M | $89.3M | $78.5M |
| Net Income | $49.0M | $60.7M | $43.1M | $22.5M |
| Op. Margin | 9.1% | 6.1% | 4.4% | 2.5% |
| Net Margin | 4.3% | 4.4% | 2.1% | 0.7% |
| Balance Sheet | ||||
| Total Assets | $963.9M | $933.4M | $1.4B | $2.2B |
| Equity | $552.8M | $614.2M | $712.7M | $779.3M |
| ROE | 8.9% | 9.9% | 6.1% | 2.9% |
Source: XBRL financial data from Astrana Health, Inc. (ASTH) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 30, 2026 | — | — | — |
10-K | Mar 12, 2026 | Dec 31, 2025 | Analysis | |
8-K | Mar 4, 2026 | — | Analysis | — |
8-K | Mar 2, 2026 | — | Analysis | — |
8-K | Jan 12, 2026 | — | — | |
10-Q | Nov 10, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 9, 2025 | Mar 31, 2025 | — | |
10-K | Mar 14, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 9, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Feb 29, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 10, 2023 | Mar 31, 2023 | — | |
10-K | Mar 1, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 7, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 9, 2022 | Jun 30, 2022 | — | |
10-Q | May 10, 2022 | Mar 31, 2022 | — | |
10-K | Feb 28, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 5, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 6, 2021 | Jun 30, 2021 | — | |
10-Q | May 7, 2021 | Mar 31, 2021 | — | |
10-K | Mar 15, 2021 | Dec 31, 2020 | — |
Frequently Asked Questions
What are the latest ASTH SEC filings in 2026?
Astrana Health, Inc. (ASTH) has filed a 10-K annual report on March 12, 2026, a 10-Q quarterly report on November 10, 2025, an 8-K current report on March 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ASTH file its most recent 10-K annual report?
Astrana Health, Inc. (ASTH) filed its most recent 10-K annual report on March 12, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ASTH 10-Q quarterly reports?
Astrana Health, Inc. (ASTH)'s most recent 10-Q quarterly report was filed on November 10, 2025. SignalX displays every ASTH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ASTH filed recently?
Astrana Health, Inc. (ASTH)'s most recent 8-K was filed on March 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ASTH insider trading activity (Form 4)?
SignalX aggregates every ASTH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ASTH file with the SEC?
Astrana Health, Inc. (ASTH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ASTH filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Astrana Health, Inc. (ASTH).
What is ASTH's SEC CIK number?
Astrana Health, Inc. (ASTH)'s SEC CIK (Central Index Key) number is 1083446. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1083446 to look up all ASTH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find ASTH return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Astrana Health, Inc. (ASTH) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Astrana Health, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 76+ filings.